University of California

Cz Biohub Sf, Llc.

Mayo Foundation for Medical Education and Research

The Cleveland Clinic Foundation

Joseph L DeRisi

Ronald N Zuckermann

Brett Anthony Helms

Robert H Silverman

Vanda A Lennon

Thomas J Kryzer

Andrew McKeon

Sean J Pittock

Eric D Chow

Graham Casey

Eric A Klein

Jenny Folkesson

Kurt S Thorn

Rafael Gòmez-Sjöberg

Emily D Crawford

Rachel Ellen Gerver

Polly M Fordyce

Don Ganem

Brian Cullen Baxter

Caleigh Mandel-Brehm

Rafael Gomez-Sjoberg

Michael R Wilson

Brian O'Donovan

Divyanshu Dubey

Paul Lebel

Rachel E Gerver

Rafael GÓMEZ-SJÖBERG

A method of measuring malarial parasitemia includes disposing a sample including red blood cells in liquid form on a sample stage, illuminating the sample with optical radiation, capturing a plurality of images of the sample, and extracting, from the one or more of the plurality of images, a set of red blood cell images. Each red blood cell image is associated with a particular red blood cell. The method also includes for each red blood cell image in the set of red blood cell images, inputting each red blood cell image into a machine learning model and generating, using the machine learning model, a classification related to a malaria parasite lifecycle stage for each of the red blood cells. The method further includes determining the malarial parasitemia for the sample.

Method for label-free imaging and classification of malaria parasites

This disclosure describes methods and compositions for detecting the presence of a Kelch-like protein 11 autoantibody in a biological sample. Also provided are methods of treating subjects with testicular cancer or a premalignant condition and paraneoplastic encephalomyelitis.

Autoantibodies as biomarker of paraneoplastic encephalitis associated with testicular cancer

A method of sample analysis is provided. In some embodiments, the method comprises: (a) digesting a mixed nucleic acid sample with a plurality of reprogrammed nucleic acid-directed endonucleases that target sequences of interest to produce a digested sample, wherein at least some of the fragments in the digested sample comprise: (i) a sequence of interest and (ii) at least one ligatable end that has been generated by endonuclease cleavage; (b) enriching for fragments that contain the sequence of interest; and (c) analyzing the enriched fragments. Kits for performing the method are also provided.

Method for finding low abundance sequences by hybridization (FLASH)

Spectrally encoded microbeads and methods and devices for making and using spectrally encoded microbeads are provided. The disclosed methods and devices facilitate the preparation and use of microbeads containing multiple lanthanide nanoparticles, which microbeads have uniquely identifiable spectral codes. The disclosed microbeads, and the methods and devices for making and using same, find use in multiplexing and high-throughput biomarker analysis.

Spectrally encoded microbeads and methods and devices for making and using same

The present invention provides for isolated nucleic acid sequences encoding viruses; isolated polypeptides comprising amino acid sequences of the virus; vectors comprising the viral nucleic acid sequences; cells comprising the vectors; antibodies and antigen binding fragments thereof which have binding specificity for the virus; methods of detecting or screening for the virus (e.g., in an individual); methods of identifying agents that inhibit the virus; methods of inducing an immune response to the virus; methods of treating disease associated with the presence of XMRV in an individual (e.g., cancer such as prostate cancer); methods of detecting asymptomatic cancer (e.g., prostate cancer); methods of identifying an individual at risk for developing cancer (e.g., prostate cancer); and kits for detecting the virus.

Gammaretrovirus associated with cancer

Growing community of inventors

San Francisco, CA, United States of America

Joseph L DeRisi